Sylvia Rothenberger Aubert

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


45 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2013 | 2007 | 2003 | 2002 | 2001 | 1999 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1988 | 1987 |
2024
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon.
Alabi A., Kokou K., Mahmoudou S., Kavishna R., Nakka S.S., Rothenberger S., Musangomunei F.P., Olubiyi B.F., Bie-Ondo J.C., Kabwende A.L. et al., 2024/10. The Journal of infection, 89 (4) p. 106237. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14DDC9627FCC]
 
Screening of Small-Molecule Libraries Using SARS-CoV-2-Derived Sequences Identifies Novel Furin Inhibitors.
Jorkesh A., Rothenberger S., Baldassar L., Grybaite B., Kavaliauskas P., Mickevicius V., Dettin M., Vascon F., Cendron L., Pasquato A., 2024/05/07. International journal of molecular sciences, 25 (10). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F00CF02496F]
2023
 
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner A., Agnandji S.T., Engler O., Hooper J.W., Kwilas S., Ricks K., Clements T.L., Jonsdottir H.R., Nakka S.S., Rothenberger S. et al., 2023/12. Clinical microbiology and infection, 29 (12) pp. 1587-1594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28B2927C0A6D]
Presence and Persistence of Andes Virus RNA in Human Semen.
Züst R., Ackermann-Gäumann R., Liechti N., Siegrist D., Ryter S., Portmann J., Lenz N., Beuret C., Koller R., Staehelin C. et al., 2023/11/17. Viruses, 15 (11) p. 2266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_034CE3FBD3D4]
SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works.
Cassari L., Pavan A., Zoia G., Chinellato M., Zeni E., Grinzato A., Rothenberger S., Cendron L., Dettin M., Pasquato A., 2023/03/01. International journal of molecular sciences, 24 (5) p. 4791. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BAA4E8CC98CA]
 
Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway
Cendron Laura, Rothenberger Sylvia, Cassari Leonardo, Dettin Monica, Pasquato Antonella, 2023. pp. 1-54 dans Secretory Proteins, Elsevier.
[DOI][Pmid][serval:BIB_98B1B3E6D97F]
2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
Rothenberger S., Hurdiss D.L., Walser M., Malvezzi F., Mayor J., Ryter S., Moreno H., Liechti N., Bosshart A., Iss C. et al., 2022/12. Nature biotechnology, 40 (12) pp. 1845-1854. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AD493D8193DB]
Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
Walser M., Mayor J., Rothenberger S., 2022/10/12. Viruses, 14 (10) p. 2242. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2AE29CC09CEA]
2021
Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen.
Rissanen I., Krumm S.A., Stass R., Whitaker A., Voss J.E., Bruce E.A., Rothenberger S., Kunz S., Burton D.R., Huiskonen J.T. et al., 2021/08/31. mBio, 12 (4) pp. e0253120. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44C482F9C556]
Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus.
Mayor J., Engler O., Rothenberger S., 2021/06/15. Microorganisms, 9 (6) p. 1306. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79BF1AA9A2FD]
Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses.
Mayor J., Torriani G., Engler O., Rothenberger S., 2021/04/16. Viruses, 13 (4) p. 685. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF22445F5B5E]
Puumala Virus Infection in Family, Switzerland.
Vetter P., L'Huillier A.G., Montalbano M.F., Pigny F., Eckerle I., Torriani G., Rothenberger S., Laubscher F., Cordey S., Kaiser L. et al., 2021/02. Emerging infectious diseases, 27 (2) pp. 658-660. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7AD496E7E77A]
2020
 
T-cell immunoglobulin and mucin (TIM) contributes to the infection of human airway epithelial cells by pseudotype viruses containing Hantaan virus glycoproteins.
Mayor J., Torriani G., Rothenberger S., Engler O., 2020/04. Virology, 543 pp. 54-62. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F2371362B4E]
2019
 
Macropinocytosis contributes to hantavirus entry into human airway epithelial cells.
Torriani G., Mayor J., Zimmer G., Kunz S., Rothenberger S., Engler O., 2019/05. Virology, 531 pp. 57-68. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E9A63758631C]
 
Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G., Trofimenko E., Mayor J., Fedeli C., Moreno H., Michel S., Heulot M., Chevalier N., Zimmer G., Shrestha N. et al., 2019/03/15. Journal of virology, 93 (6). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D5371F74AB92]
2016
Conserved Endonuclease Function of Hantavirus L Polymerase.
Rothenberger S., Torriani G., Johansson M.U., Kunz S., Engler O., 2016. Viruses, 8 (5) pp. E108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C680A6AAF4A]
2015
 
Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C., Rothenberger S., Martínez-Sobrido L., de la Torre J.C., Kunz S., 2015. Journal of Virology, 89 (12) pp. 6240-6250. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1620C41CAC48]
2013
Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan.
Moraz M.L., Pythoud C., Turk R., Rothenberger S., Pasquato A., Campbell K.P., Kunz S., 2013/05. Cellular microbiology, 15 (5) pp. 689-700. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_493B45AE6186]
2007
 
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.
Butticaz C., Michielin O., Wyniger J., Telenti A., Rothenberger S., 2007. Journal of virology, 81 (3) pp. 1502150-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CDB1E001B3A9]
2003
 
Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site.
Rothenberger S., Burns K., Rousseaux M., Tschopp J., Bron C., 2003. Oncogene, 22 (36) pp. 5614-5618.
[DOI][WoS][Pmid][serval:BIB_9597D49B6CAE]
2002
 
Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region.
Rothenberger S., Rousseaux M., Knecht H., Bender F.C., Legler D.F., Bron C., 2002. Cellular and Molecular Life Sciences, 59 (1) pp. 171-180.
[DOI][WoS][Pmid][serval:BIB_08DCD33E0ED0]
2001
 
The role of Epstein-Barr virus in neoplastic transformation
Knecht H., Berger C., Rothenberger S., Odermatt B. F., Brousset P., 2001. Oncology, 60 (4) pp. 289-302.
[DOI][WoS][Pmid][serval:BIB_682742A094A5]
1999
 
Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease
Knecht H., Berger C., McQuain C., Rothenberger S., Bachmann E., Martin J., Esslinger C., Drexler H. G., Cai Y. C., Quesenberry P. J. et al., 1999/11. Oncogene, 18 (50) pp. 7161-7.
[DOI][WoS][Pmid][serval:BIB_09941541BCC8]
 
Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations
Berger C., Rothenberger S., Bachmann E., McQuain C., Nadal D., Knecht H., 1999/05. International Journal of Cancer, 81 (3) pp. 371-5.
[WoS][Pmid][serval:BIB_9E157B1CD477]
1997
 
Molecular and functional analysis of the Epstein-Barr virus LMP1 oncogene promoter in lymphoproliferative diseases
Rothenberger S., Bachmann E., Knecht H., 1997/12. Experimental Hematology, 25 (13) pp. 1326-32.
[WoS][Pmid][serval:BIB_E2F7CEC59928]
 
Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription
Rothenberger S., Bachmann E., Berger C., McQuain C., Odermatt B. F., Knecht H., 1997/05. Oncogene, 14 (17) pp. 2123-6.
[DOI][WoS][Pmid][serval:BIB_8651B79C0021]
 
Expression of cell surface GPI-anchored human p97 in baculovirus-infected insect cells.
Kennard M.L., Shimizu K.Y., Gabathuler R., Rothenberger S., Theilmann D., Jefferies W.A., 1997. Biotechnology and Bioengineering, 55 (1) pp. 41-53.
[DOI][WoS][Pmid][serval:BIB_C2CBB377716A]
1996
 
Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology
Knecht H., McQuain C., Martin J., Rothenberger S., Drexler H. G., Berger C., Bachmann E., Kittler E. L., Odermatt B. F., Quesenberry P. J., 1996/09. Oncogene, 13 (5) pp. 947-53.
[WoS][Pmid][serval:BIB_EFADE9D3B394]
 
Pumping iron in the '90s
Jefferies W. A., Gabathuler R., Rothenberger S., Food M., Kennard M. L., 1996/06. Trends in Cell Biology, 6 (6) pp. 223-8.
[DOI][WoS][Pmid][serval:BIB_6B3C8DF06CFE]
 
Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium
Rothenberger S., Food M. R., Gabathuler R., Kennard M. L., Yamada T., Yasuhara O., McGeer P. L., Jefferies W. A., 1996/03. Brain Research, 712 (1) pp. 117-21.
[DOI][WoS][Pmid][serval:BIB_E3A2FF3F67B5]
 
Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin
Jefferies W. A., Food M. R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., McGeer P. L., 1996/03. Brain Research, 712 (1) pp. 122-6.
[DOI][WoS][Pmid][serval:BIB_BBC2E49BCC61]
 
Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations
Knecht H., Raphael M., McQuain C., Rothenberger S., Pihan G., Camilleri-Broet S., Bachmann E., Kershaw G. R., Ryan S., Kittler E. L. et al., 1996/02. Blood, 87 (3) pp. 876-81.
[WoS][Pmid][serval:BIB_0E3E9B44CF9F]
1995
 
Detection of restricted isoform expression and tyrosine phosphatase activity of CD45 in murine dendritic cells
Haidl I. D., Ng D. H., Rothenberger S., Johnson P., Jefferies W. A., 1995/12. European Journal of Immunology, 25 (12) pp. 3370-4.
[DOI][WoS][Pmid][serval:BIB_90AEE656528F]
 
EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene
Klein C., Rothenberger S., Niemeyer C., Bachmann E., Odermatt B., Bohm N., Brandis M., Knecht H., 1995/12. British Journal of Haematology, 91 (4) pp. 938-40.
[DOI][WoS][Pmid][serval:BIB_785D2690546B]
 
A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma
Knecht H., Martius F., Bachmann E., Hoffman T., Zimmermann D. R., Rothenberger S., Sandvej K., Wegmann W., Hurwitz N., Odermatt B. F. et al., 1995/03. Leukemia, 9 (3) pp. 458-65.
[WoS][Pmid][serval:BIB_B5B2C7A95BAD]
 
Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders
Knecht H., Bachmann E., Brousset P., Rothenberger S., Einsele H., Lestou V. S., Delsol G., Bachmann F., Ambros P. F., Odermatt B. F., 1995/02. Oncogene, 10 (3) pp. 523-8.
[WoS][Pmid][serval:BIB_1C70ECFB0AC1]
 
PCR directed detection of deletions and variable numbers of internal repeats within the LMP1 oncogene of EBV.
Knecht H., Bachmann E, Rothenberger S, Odermatt B F, 1995. pp. 235-245 dans Becker Y, Darai G (eds.) Protocols for Diagnosis of Human and Animal Virus Diseases, Heidelberg : Springler Verlag.
[serval:BIB_BAAC003A65D7]
1994
 
Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease
Brousset P., Schlaifer D., Meggetto F., Bachmann E., Rothenberger S., Pris J., Delsol G., Knecht H., 1994/10. Blood, 84 (8) pp. 2447-51.
[WoS][Pmid][serval:BIB_96575D443B94]
 
Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein.
Food M.R., Rothenberger S., Gabathuler R., Haidl I.D., Reid G., Jefferies W.A., 1994/01. Journal of Biological Chemistry, 269 (4) pp. 3034-3040. Peer-reviewed.
[WoS][Pmid][serval:BIB_1DDAA51B05BE]
1993
 
The internalization signal and the phosphorylation site of transferrin receptor are distinct from the main basolateral sorting information
Dargemont C., Le Bivic A., Rothenberger S., Iacopetta B., Kuhn L. C., 1993/04. EMBO Journal, 12 (4) pp. 1713-21.
[WoS][Pmid][serval:BIB_83F12B4B8567]
1992
 
In vivo and in vitro modulation of the mRNA-binding activity of iron-regulatory factor. Tissue distribution and effects of cell proliferation, iron levels and redox state
Mullner E. W., Rothenberger S., Muller A. M., Kuhn L. C., 1992/09. European Journal of Biochemistry, 208 (3) pp. 597-605.
[DOI][WoS][Pmid][serval:BIB_F4DDD2359D07]
1991
 
Expression of human transferrin receptor
Neupert B., Mullner E., Rothenberger S., Seiser C., Teixeira S., Thompson N. A., Emery-Goodman A., Kuhn L. C., 1991. Current Studies in Hematology and Blood Transfusion 58 pp. 109-14.
[WoS][Pmid][serval:BIB_8FEED0565C72]
1990
 
The mRNA-binding protein which controls ferritin and transferrin receptor expression is conserved during evolution
Rothenberger S., Mullner E. W., Kuhn L. C., 1990/03. Nucleic Acids Research, 18 (5) pp. 1175-9.
[DOI][WoS][Pmid][serval:BIB_A066094D5601]
1988
 
A role for the cytoplasmic domain in transferrin receptor sorting and coated pit formation during endocytosis
Iacopetta B. J., Rothenberger S., Kuhn L. C., 1988/08. Cell, 54 (4) pp. 485-9.
[DOI][WoS][Pmid][serval:BIB_7FD6825684DF]
1987
 
Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site
Rothenberger S., Iacopetta B. J., Kuhn L. C., 1987/05. Cell, 49 (3) pp. 423-31.
[DOI][WoS][Pmid][serval:BIB_BE7E2107746A]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University